Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 4,787 $ 6,830
Marketable debt securities 8,969 21,933
Restricted cash – security deposit 50 50
Prepaid expenses and other current assets 1,737 5,719
Total current assets 15,543 34,532
Non-current assets:    
Leasehold improvements and equipment - net 1,923 2,091
Operating lease right-of-use assets - net 3,064 3,613
Finance lease right-of-use assets - net 21 30
In-process research and development 3,017 3,017
Goodwill 1,336 1,336
Restricted cash - security deposit 200 200
Total non-current assets 9,561 10,287
Total assets 25,104 44,819
Current liabilities:    
Accounts payable 514 618
Accrued expenses and other liabilities 1,447 3,099
Operating lease liabilities - current 656 562
Financing lease liabilities - current 5 7
Total current liabilities 2,622 4,286
Non-current liabilities:    
Deferred tax liability 341 341
Operating lease liabilities - net of current portion 2,877 3,533
Financing lease liabilities - net of current portion 18 22
Total non-current liabilities 3,236 3,896
Total liabilities 5,858 8,182
Stockholders’ equity:    
Common stock par value $0.0001 per share, 500,000,000 shares authorized at December 31, 2023 and 2022, respectively; 217,264,526 issued and outstanding as of December 31, 2023 and 2022, respectively 22 22
Additional paid-in capital 195,018 190,070
Accumulated deficit (175,573) (152,631)
Accumulated other comprehensive loss (221) (824)
Total stockholders’ equity 19,246 36,637
Total liabilities and stockholders’ equity $ 25,104 $ 44,819